Cabaletta Bio, Inc.
NasdaqGS:CABA
Sector
Location
Market Cap
USD 148.17 M
Share Price
USD 1.62
Avg Daily Volume
1,888,054
Change (1 day)
-8.48%
Change (1 year)
-67.40%
Change (YTD)
-28.63%
Cabaletta Bio, Inc. Key Metrics 2018 - 2025
This table shows the Key Metrics for Cabaletta Bio, Inc. going from 2018 until 2025. Key metrics are specific quantitative measures used to assess the performance and progress of a company, often tailored to its industry and objectives, providing insights into growth, profitability, and operational efficiency.
Key Metrics
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
Eli Lilly and Company
USD 703.21
LLY
+5.16
0.74%
AbbVie Inc.
USD 206.19
ABBV
-0.38
-0.18%
Roche Holding AG
USD 337.32
RO.SW
+4.54
1.36%
Novo Nordisk A/S
USD 54.16
NOVO-B.CO
-0.02
-0.03%
Novartis AG
USD 124.85
NOVN.SW
+0.78
0.63%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Merck & Co., Inc.
USD 84.93
MRK
+0.71
0.84%
Thermo Fisher Scientific Inc.
USD 498.29
TMO
+10.75
2.21%
Amgen Inc.
USD 295.55
AMGN
+2.93
1.00%
Gilead Sciences, Inc.
USD 117.98
GILD
-0.01
-0.01%
Pfizer Inc.
USD 25.32
PFE
+0.25
1.00%
Sanofi
USD 100.73
SAN.PA
+0.93
0.94%
Vertex Pharmaceuticals Incorporated
USD 390.76
VRTX
+0.88
0.23%
Bristol-Myers Squibb Company
USD 48.34
BMY
+0.15
0.31%
Chugai Pharmaceutical Co., Ltd.
USD 43.52
4519.T
-0.76
-1.72%